Literature DB >> 22017210

Lesional Th17 cells and regulatory T cells in bullous pemphigoid.

Masataka Arakawa, Teruki Dainichi, Norito Ishii, Takahiro Hamada, Tadashi Karashima, Takekuni Nakama, Shinichiro Yasumoto, Daisuke Tsuruta, Takashi Hashimoto.   

Abstract

Th17 cells play crucial roles in the pathogenesis of autoimmune diseases. We previously reported that Th17 cells are recruited to the lesional skin in pemphigus vulgaris (PV) and pemphigus foliaceus (PF). The aim of this study was to evaluate lesional Th17 cells and Treg cells in bullous pemphigoid (BP). Correlations between these cells and disease severity of BP were also evaluated. Immunohistochemical studies showed that both IL-17+ and Foxp3+ cells were present in higher numbers in BP lesions, compared with control skin. IL-17/CD4 ratio in BP was significantly higher than that in PF. Foxp3/CD4 ratio in BP was significantly less than that in either PV or PF. There were no obvious correlations between these cells and disease severity of BP. This study suggests that, compared with pemphigus, BP shows more Th17 cell-related inflammation and less Treg-related regulation.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22017210     DOI: 10.1111/j.1600-0625.2011.01378.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  27 in total

Review 1.  Targeted Therapies for Autoimmune Bullous Diseases: Current Status.

Authors:  Kyle T Amber; Roberto Maglie; Farzan Solimani; Rüdiger Eming; Michael Hertl
Journal:  Drugs       Date:  2018-10       Impact factor: 9.546

2.  T cell participation in autoreactivity to NC16a epitopes in bullous pemphigoid.

Authors:  W J Pickford; V Gudi; A M Haggart; B J Lewis; R Herriot; R N Barker; A D Ormerod
Journal:  Clin Exp Immunol       Date:  2015-05       Impact factor: 4.330

Review 3.  Engineered antigen-specific regulatory T cells for autoimmune skin conditions.

Authors:  Zhussipbek Mukhatayev; Yekaterina O Ostapchuk; Deyu Fang; I Caroline Le Poole
Journal:  Autoimmun Rev       Date:  2021-01-18       Impact factor: 17.390

4.  Bullous Pemphigoid-like Eruption Triggered by Targeted Therapy for Metastatic Melanoma.

Authors:  Hanna Eriksson; Johan Hansson; Britta Krynitz; Giuseppe Masucci; Ada Girnita; Jan Lapins; Auris O Huen; Hussein A Tawbi; Michael A Davies; Michael T Tetzlaff; Jonathan L Curry
Journal:  Acta Derm Venereol       Date:  2020-11-26       Impact factor: 3.875

5.  Expression of interleukin-17 in lesions of erythema multiforme may indicate a role for T helper 17 cells.

Authors:  Zeynep Meltem Akkurt; Derya Uçmak; Gül Türkcü; Hatice Yüksel; Kenan Yildiz; Mustafa Arıca
Journal:  Cent Eur J Immunol       Date:  2014-10-14       Impact factor: 2.085

6.  Bullous Pemphigoid Accompanied by Aplastic Anemia: The Induction of IL-17-Producing Cells in the Affected Areas of the Skin.

Authors:  Taku Fujimura; Aya Kakizaki; Yumi Kambayashi; Sadanori Furudate; Setsuya Aiba
Journal:  Case Rep Dermatol       Date:  2012-10-12

7.  Activation of Blood Coagulation in Two Prototypic Autoimmune Skin Diseases: A Possible Link with Thrombotic Risk.

Authors:  Massimo Cugno; Alberto Tedeschi; Alessandro Borghi; Paolo Bucciarelli; Riccardo Asero; Luigia Venegoni; Samantha Griffini; Elena Grovetti; Emilio Berti; Angelo Valerio Marzano
Journal:  PLoS One       Date:  2015-06-09       Impact factor: 3.240

8.  IL-17 expression in dermatitis herpetiformis and bullous pemphigoid.

Authors:  Agnieszka Zebrowska; Malgorzata Wagrowska-Danilewicz; Marian Danilewicz; Olga Stasikowska-Kanicka; Anna Cynkier; Anna Sysa-Jedrzejowska; Elzbieta Waszczykowska
Journal:  Mediators Inflamm       Date:  2013-07-21       Impact factor: 4.711

9.  Overexpression of interleukin-23 and interleukin-17 in the lesion of pemphigus vulgaris: a preliminary study.

Authors:  Jixin Xue; Wenting Su; Zhiwei Chen; Youhui Ke; Xiaojing Du; Qiaochu Zhou
Journal:  Mediators Inflamm       Date:  2014-05-11       Impact factor: 4.711

10.  Innate immune cell-produced IL-17 sustains inflammation in bullous pemphigoid.

Authors:  Sébastien Le Jan; Julie Plée; David Vallerand; Aurélie Dupont; Elodie Delanez; Anne Durlach; Patricia L Jackson; J Edwin Blalock; Philippe Bernard; Frank Antonicelli
Journal:  J Invest Dermatol       Date:  2014-07-19       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.